Early Outcomes of Transcatheter Aortic Valve Implantation with Next-Generation Balloon-Expandable Myval Transcatheter Heart Valve: Single-Center Experience from Iraq
Journal of the Saudi Heart Association · 07.06.2024 · 36 (1)
DOI: 10.37616/2212-5043.1370 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Saudi Heart Association, online erschienen am 07.06.2024. Verfasst von Khalid Ibrahim Amber und 1 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objectives
Transcatheter aortic valve implantation (TAVI) is a minimally invasive percutaneous procedure for the treatment of elderly patients with symptomatic severe aortic stenosis. The study aimed to determine immediate (in-hospital) and short-term (30-day) outcomes of TAVI with next-generation balloon-expandable Myval transcatheter heart valve (THV) at a single-centre in Iraq.
Methods
During January 2019 to January 2024, a total of 100 symptomatic severe aortic stenosis patients who underwent TAVI using Myval THV at Al-Najaf Cardiac Center, Iraq were enrolled. The procedure was done under local anesthesia and conscious sedation via transfemoral approach, using balloon-expandable Myval THV. All patients were followed-up at post-procedure, during hospitalization and thereafter periodically for procedural and clinical outcomes and complications.
Results
The mean age of these patients was 73.8 ± 6.5 years and there were equal proportion of male and female patients. Immediate post-procedure and short-term mortality was 1%, while vascular complications, moderate paravalvular leak and overall conduction abnormalities were 11%, 4% and 21%, respectively at 30-day follow-up. Only six patients (6%) required a new permanent pacemaker. Post-procedural mean pressure gradient was 5.44 ± 2.38 mmHg. None of the treated patients experienced coronary artery occlusion. Cerebrovascular complication (transient and non-disabling) was noted in one patient.
Conclusion
In patients with native symptomatic severe aortic stenosis, TAVI using novel, next-generation, ballon-expandable Myval THV offers a safe and reliable treatment option with good procedural success and survival rates and fewer complications.
Zitieren
APA
Amber, K. I., & Majeed, A. J. (2024). Early Outcomes of Transcatheter Aortic Valve Implantation with Next-Generation Balloon-Expandable Myval Transcatheter Heart Valve: Single-Center Experience from Iraq. Journal of the Saudi Heart Association, 36(1). https://doi.org/10.37616/2212-5043.1370
Vancouver
Amber KI, Majeed AJ. Early Outcomes of Transcatheter Aortic Valve Implantation with Next-Generation Balloon-Expandable Myval Transcatheter Heart Valve: Single-Center Experience from Iraq. Journal of the Saudi Heart Association. 2024;36(1). doi:10.37616/2212-5043.1370
BibTeX
@article{Amber2024,
author = {Amber, Khalid Ibrahim and Majeed, Ammar Jabbar},
title = {Early Outcomes of Transcatheter Aortic Valve Implantation with Next-Generation Balloon-Expandable Myval Transcatheter Heart Valve: Single-Center Experience from Iraq},
journal = {Journal of the Saudi Heart Association},
year = {2024},
volume = {36},
number = {1},
doi = {10.37616/2212-5043.1370}
}
EUVIMED